GB9215178D0 - Antiviral combinations - Google Patents
Antiviral combinationsInfo
- Publication number
- GB9215178D0 GB9215178D0 GB929215178A GB9215178A GB9215178D0 GB 9215178 D0 GB9215178 D0 GB 9215178D0 GB 929215178 A GB929215178 A GB 929215178A GB 9215178 A GB9215178 A GB 9215178A GB 9215178 D0 GB9215178 D0 GB 9215178D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pct
- combinations
- sec
- pharmaceutically acceptable
- acceptable derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000840 anti-viral effect Effects 0.000 title 1
- JXYPNRIYAMXJSE-UHFFFAOYSA-N 1,4-diazepin-6-one Chemical compound O=C1C=NC=CN=C1 JXYPNRIYAMXJSE-UHFFFAOYSA-N 0.000 abstract 1
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
PCT No. PCT/EP93/01847 Sec. 371 Date Dec. 29, 1994 Sec. 102(e) Date Dec. 29, 1994 PCT Filed Jul. 13, 1993 PCT Pub. No. WO94/02155 PCT Pub. Date Feb. 3, 1994Combinations of (2R, cis)-4-amino-1-(2-hydmxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one or a pharmaceutically acceptable derivative thereof and 11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,3-b;21,31-e][1,4]diazepin-6-one or a pharmaceutically acceptable derivative thereof, pharmaceutical formulations of such combinations and the use of such combinations and formulations to treat viral infections, in particular HIV infections, are described.
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929215178A GB9215178D0 (en) | 1992-07-16 | 1992-07-16 | Antiviral combinations |
DK93915909T DK0650363T3 (en) | 1992-07-16 | 1993-07-13 | Antiviral combinations |
PCT/EP1993/001847 WO1994002155A1 (en) | 1992-07-16 | 1993-07-13 | Antiviral combinations |
ES93915909T ES2111755T3 (en) | 1992-07-16 | 1993-07-13 | ANTIVIRIC COMBINATIONS. |
AU45689/93A AU672022B2 (en) | 1992-07-16 | 1993-07-13 | Antiviral combinations |
AT93915909T ATE162401T1 (en) | 1992-07-16 | 1993-07-13 | ANTIVITIAL COMPOSITIONS |
CA002140238A CA2140238C (en) | 1992-07-16 | 1993-07-13 | Antiviral combinations |
EP93915909A EP0650363B1 (en) | 1992-07-16 | 1993-07-13 | Antiviral combinations |
JP6504124A JPH07508998A (en) | 1992-07-16 | 1993-07-13 | Antiviral combination |
US08/356,322 US5612333A (en) | 1992-07-16 | 1993-07-13 | Antiviral combinations |
DE69316621T DE69316621T2 (en) | 1992-07-16 | 1993-07-13 | ANTIVITAL COMPOSITIONS |
GR980400314T GR3026141T3 (en) | 1992-07-16 | 1998-02-12 | Antiviral combinations. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929215178A GB9215178D0 (en) | 1992-07-16 | 1992-07-16 | Antiviral combinations |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9215178D0 true GB9215178D0 (en) | 1992-08-26 |
Family
ID=10718844
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB929215178A Pending GB9215178D0 (en) | 1992-07-16 | 1992-07-16 | Antiviral combinations |
Country Status (12)
Country | Link |
---|---|
US (1) | US5612333A (en) |
EP (1) | EP0650363B1 (en) |
JP (1) | JPH07508998A (en) |
AT (1) | ATE162401T1 (en) |
AU (1) | AU672022B2 (en) |
CA (1) | CA2140238C (en) |
DE (1) | DE69316621T2 (en) |
DK (1) | DK0650363T3 (en) |
ES (1) | ES2111755T3 (en) |
GB (1) | GB9215178D0 (en) |
GR (1) | GR3026141T3 (en) |
WO (1) | WO1994002155A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9503850D0 (en) * | 1995-02-25 | 1995-04-19 | Glaxo Group Ltd | Medicaments |
US7713739B1 (en) | 2000-11-17 | 2010-05-11 | Novartis Vaccines And Diagnostics, Inc. | Microparticle-based transfection and activation of dendritic cells |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2660917B1 (en) * | 1990-04-11 | 1992-11-20 | Perrier Rene | GRIPPERS AND MACHINE FOR PROCESSING OBJECTS, PARTICULARLY BOTTLES, THUS EQUIPPED. |
GB9009861D0 (en) * | 1990-05-02 | 1990-06-27 | Glaxo Group Ltd | Chemical compounds |
WO1992017159A2 (en) * | 1991-04-03 | 1992-10-15 | Richardson-Vicks Inc. | Stabilized emulsion compositions for imparting an artificial tan to human skin |
ES2083668T5 (en) * | 1991-05-16 | 2001-06-16 | Glaxo Group Ltd | ANTIVIRICAL COMBINATIONS CONTAINING NUCLEOSIDE ANALOGS. |
-
1992
- 1992-07-16 GB GB929215178A patent/GB9215178D0/en active Pending
-
1993
- 1993-07-13 DK DK93915909T patent/DK0650363T3/en active
- 1993-07-13 WO PCT/EP1993/001847 patent/WO1994002155A1/en active IP Right Grant
- 1993-07-13 JP JP6504124A patent/JPH07508998A/en active Pending
- 1993-07-13 EP EP93915909A patent/EP0650363B1/en not_active Expired - Lifetime
- 1993-07-13 AU AU45689/93A patent/AU672022B2/en not_active Expired
- 1993-07-13 AT AT93915909T patent/ATE162401T1/en active
- 1993-07-13 CA CA002140238A patent/CA2140238C/en not_active Expired - Lifetime
- 1993-07-13 ES ES93915909T patent/ES2111755T3/en not_active Expired - Lifetime
- 1993-07-13 DE DE69316621T patent/DE69316621T2/en not_active Expired - Lifetime
- 1993-07-13 US US08/356,322 patent/US5612333A/en not_active Expired - Lifetime
-
1998
- 1998-02-12 GR GR980400314T patent/GR3026141T3/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2140238C (en) | 2004-04-20 |
WO1994002155A1 (en) | 1994-02-03 |
EP0650363B1 (en) | 1998-01-21 |
GR3026141T3 (en) | 1998-05-29 |
EP0650363A1 (en) | 1995-05-03 |
DK0650363T3 (en) | 1998-09-21 |
ES2111755T3 (en) | 1998-03-16 |
DE69316621T2 (en) | 1998-05-07 |
US5612333A (en) | 1997-03-18 |
AU4568993A (en) | 1994-02-14 |
ATE162401T1 (en) | 1998-02-15 |
JPH07508998A (en) | 1995-10-05 |
AU672022B2 (en) | 1996-09-19 |
CA2140238A1 (en) | 1994-02-03 |
DE69316621D1 (en) | 1998-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW366347B (en) | Antiviral pharmaceutical compositions comprising 1,3-oxathiolane nucleoside analogues | |
EP1062950A3 (en) | 1,3 Oxathiolane nucleoside analogues | |
GB9104740D0 (en) | Antiviral nucleoside combination | |
ES2172533T3 (en) | USE OF NONAPEPTIDES AND DECAPEPTIDES FOR THE PREPARATION OF A MEDICINAL PRODUCT TO COMBAT AIDS. | |
GEP20022647B (en) | Synergistic Combinations | |
AU591125B2 (en) | Therapeutic nucleosides | |
GEP19991834B (en) | Crystalline Oxathiolane Derivatives | |
PT871465E (en) | USE OF RITONAVIR (ABT-538) TO IMPROVE THE CYTOCHROME P450 METABOLIZED METABOLIZED DRUG PHARMACOKINETICS IN AN AIDS TREATMENT METHOD | |
GEP20074099B (en) | 3-β-D-RIBOFURANO-SYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF | |
MX9200361A (en) | NEW USE OF THE ADENOSINE ANTAGONIST. | |
WO2002038171A3 (en) | METHODS FOR TREATING DISEASES CAUSED BY DEFICIENCIES OF α-L-IDURONIDASE | |
MY127808A (en) | Use of dideoxy nucleoside analogues in the treatment of viral infections | |
TW371662B (en) | Antiviral acyclic phosphonomethoxyalkyl substituted alkenyl purine and pyrimidine derivatives | |
GB9215178D0 (en) | Antiviral combinations | |
MY116242A (en) | Pharmaceutical compositions containing lamivudine . | |
HUP0000344A2 (en) | Pharmaceutical compositions containing lamivudine and zidovudine | |
CA2285463A1 (en) | A combination therapy for hiv infections | |
CA2120001A1 (en) | Flavopereirine-based pharmaceutical composition and use thereof for treating hiv | |
AU2880595A (en) | Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses | |
AR005551A1 (en) | A PHARMACEUTICAL COMBINATION PRODUCT COMPRISING AN ANALOG NUCLEOSIDE AND IMMUNOSUPPRESSANTS IN COMBINATION WITH A CYTOTOXIC AGENT FOR THE TREATMENT OF INFECTIONS WITH THE SIMPLE HERPES VIRUS | |
AP9801307A0 (en) | Use of 3-amino-4-hydroxbenzoic acid for treatment of retroviral infections. | |
Gonslaves | Throw down your crutches and walk | |
CA2244268A1 (en) | Nucleoside analogs in combination therapy of herpes simplex infections | |
MY103900A (en) | 6-substituted 2'', 3''-dideoxynucleosides and pharmaceutical compositions |